Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail
-

Miacalcin (calcitonin-salmon) Injection and Nasal Spray

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- October 2009 and April 2012

 

April 2012

Summary View

 

Miacalcin (Calcitonin-Salmon) Nasal Spray and Injection
*Tremors
 

ADVERSE REACTIONS

Dermatologic/Hypersensitivity
Central and Peripheral Nervous System:
  • Tremor

  

October 2009 

Summary View

 

Miacalcin (Calcitonin-Salmon) Injection

 

ADVERSE REACTIONS

Dermatologic/Hypersensitivity
  • Administration of calcitonin-salmon has been reported in a few cases to cause serious allergic-type reactions (e.g., bronchospasm, swelling of the tongue or throat, anaphylactic shock), including very rare reports of death attributed to anaphylaxis.
Gastrointestinal 
  • abdominal pain, diarrhea

 

-
-